Petra Duda

Petra Duda is an accomplished professional specializing in clinical development within the pharmaceutical industry, currently serving as SVP of Clinical Development at Inozyme Pharma since November 2024. Previous roles include VP and Executive Director at UCB, and Executive Director and Senior Director of Clinical Research at Ra Pharmaceuticals. Petra also held the position of Medical Director at Sarepta Therapeutics and progressed through various roles at Biogen and Biogen Idec, culminating as Director of Medical Research. Early career experiences include Chief Resident at the Rehabilitation Clinic Valens and multiple roles at University Hospital Basel, where Petra focused on multiple sclerosis research. Petra's educational background includes an MD PhD in Medicine and Biology from the University of Bern.